Search by Drug Name or NDC
NDC 50090-4540-00 Geodon 20 mg/mL Details
Geodon 20 mg/mL
Geodon is a INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is ZIPRASIDONE MESYLATE.
MedlinePlus Drug Summary
Ziprasidone injection is used to treat episodes of agitation in people who have schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Ziprasidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
Related Packages: 50090-4540-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ziprasidone Injection
Product Information
| NDC | 50090-4540 |
|---|---|
| Product ID | 50090-4540_88cf678e-342c-4abf-bf36-db067b915e70 |
| Associated GPIs | 59400085202120 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Geodon |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ziprasidone mesylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | ZIPRASIDONE MESYLATE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Atypical Antipsychotic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020919 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-4540-00 (50090454000)
| NDC Package Code | 50090-4540-0 |
|---|---|
| Billing NDC | 50090454000 |
| Package | 1 mL in 1 VIAL, SINGLE-DOSE (50090-4540-0) |
| Marketing Start Date | 2019-09-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |